Pill/tablet themed deal toy marking the sale by Bayer Korea of the drug Mercilon.
(6LACB53)
These custom designs highlight deal toys within the healthcare space, but also include vial embedments for drug launches, and commemoratives for FDA approval milestones, therapeutic studies, in-human testing, and other industry landmarks.
Pill/tablet themed deal toy marking the sale by Bayer Korea of the drug Mercilon.
(6LACB53)Lucite commemorative marking a research and development joint venture between Massachusetts-based CRISPR, and German drug company Bayer. The collaboration will center on CRISPR’s gene-editing technology, and focus on the treatment of conditions such as congenital heart disease, blood disorders, and blindness.
(6AGP903)Deal tombstone marking the acquisition of Paris-based HRA Pharma. Goldman Sachs and private equity group Astorg were the purchasers.
(6LACA69)Custom commemorative marking the global collaboration between Janssen Biotech and TESARO involving the treatment of prostate cancer, with a design incorporating a spinning heart.
(6ALR124)Deal tombstone marking the acquisition of MIOX, a water purification firm based in Albuquerque, New Mexico. MIOX’s industrial-scale systems are used by municipalities and commercial businesses.
(6ALR156)Deal tombstone marking the sale by UDG Heathcare of its Irish drug wholesaler business to global pharmaceutical wholesaler McKesson. U.S.-based McKesson was represented in the transaction by Goldman Sachs.
(6LJWA83)Hospital bed deal tombstone marking an investment in healthcare provider Hygeia Nigeria Limited.Â
(6AEK877)Deal toys in the healthcare and pharmaceutical space reflect a broad range of financial transactions. These deals involve an array of industry players, including drug companies, hospital chains, medtech firms, manufacturers of medical devices, developers of diagnostic equipment, senior living facilities, pharmacies, and testing laboratories, as well as healthcare-focused funds and venture capital firms.
The transactions themselves include mergers and acquisitions, initial public offerings, bond issues, financings, private placements, and early-stage funding rounds.
But also represented here are transactions more unique to the sector, such as drug licensing, royalty, and commercialization agreements.
The custom designs in these galleries also celebrate non-financial industry achievements and milestones. You will see here, for instance, commemoratives involving submissions and approvals from the Food & Drug Administration (FDA) and European Medicines Agency (EMA), therapeutic studies, joint ventures, successful preclinical and in-human testing stages, and product launches.
These milestones can be commemorated with designs incorporating items unique to the specific event, achievement, or innovation being recognized. These design options include, for example, Lucite embedments of actual drug vials and medical devices.
You’ll also find here commemoratives for a variety of other sector-related events. These include custom awards and gifts honoring speakers and attendees at national and international health summits and medical conferences.
"*" indicates required fields
